What is dysbiosis and what are its consequences?
For World Microbiome Day, let’s talk about gut dysbiosis and its detrimental impact in human health.
Home »
Articles
AB-BIOTICS’ AB21® and LipiGO®, winners of the NutraIngredients Awards
We are thrilled to announce that our two finalists, AB21® and LipiGO®, have both taken home the crown in their respective categories for this year’s NutraIngredients Awards
AB-BIOTICS and Alifarm merger plan
AB-BIOTICS acquired Pharma GMP and Probiotics production facility Alifarm, (Llicè de Vall, Barcelona) to further develop its Probiotics packaging solutions for their customers.
AB-BIOTICS call notice for General Shareholders Meeting
AB-BIOTICS releases 2021 financial accounts and General Shareholders Meeting information, Barcelona, at May 5th 2022, AB-BIOTICS has posted call notice
AB21® and LipiGO®, finalists for the 2022 NutraIngredients Awards
Nutraingredients has announced the finalists for the 8th edition of the awards. We are pleased to announce the nomination of LipiGO® for the Weight Management category and AB21® as the product of the year for the Probiotic category.
AB-KOLICARE™ probiotic strains show remarkable properties for infant gastrointestinal disorders (FGIDs)
Frontiers has published the latest clinical data of AB-KOLICARE™, that shows quite promising results on infant colic. This probiotic formulation leads AB-BIOTICS pediatric line, containing two bacteria strains with a battery of benefits for babies.
AB21 spreads presence in Asia with AceBiome
A newly published clinical trial in Gut Microbes – a top journal reporting the latest science in microbiota – has confirmed that Kaneka Group / AB-Biotics’ AB21 probiotic formulation exhibits significant positive effects in COVID-19 outpatients.
AB21 demonstrates benefit in COVID-19 outpatients
A newly published clinical trial in Gut Microbes – a top journal reporting the latest science in microbiota – has confirmed that Kaneka Group / AB-Biotics’ AB21 probiotic formulation exhibits significant positive effects in COVID-19 outpatients.
Pharex and AB-BIOTICS, probiotic for cholesterol in Philippines
To offer a preventive, natural solution to Filipinos in risk of high cholesterol, Pharex and AB-BIOTICS have recently launched Biome Lipidec.
AB-LIFE, first probiotic approved in Brazil for high cholesterol
AB-LIFE probiotic formulation has recently been approved by the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitária, Anvisa) as a safe and efficient food supplement to help reduce cholesterol levels.
